Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Devic Disease”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT04227470
What this trial is testing

HBM9161 in NMOSD Patients

Who this might be right for
NMO Spectrum Disorder
Harbour BioMed (Guangzhou) Co. Ltd. 9
Large-scale testing (Phase 3)Study completedNCT02200770
What this trial is testing

N-MOmentum: A Clinical Research Study of Inebilizumab in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica and Neuromyelitis Optica Spectrum Disorders
MedImmune LLC 231
Not applicableStudy completedNCT02850705
What this trial is testing

The French Cohort and Biobank of Devic's Neuromyelitis Optica and Related Neurological Disorders (NMOSD) (NOMADMUS)

Who this might be right for
Neuromyelitis Optica Spectrum DisordersNeuromyelitis Optica Spectrum Related Disorders
Hospices Civils de Lyon 1,787
Testing effectiveness (Phase 2)WithdrawnNCT06673394
What this trial is testing

Eculizumab For Acute Attack of Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Tianjin Medical University General Hospital
Large-scale testing (Phase 3)WithdrawnNCT03829566
What this trial is testing

Autologous Transplant To End NMO Spectrum Disorder

Who this might be right for
Neuromyelitis OpticaDevic's DiseaseNMO Spectrum Disorder
Northwestern University
Testing effectiveness (Phase 2)Looking for participantsNCT05504694
What this trial is testing

Ofatumumab in AQP4-IgG Seropositive NMOSD

Who this might be right for
Neuromyelitis Optica Spectrum Disorder
Tang-Du Hospital 5
Not applicableUnknownNCT01920867
What this trial is testing

Stem Cell Ophthalmology Treatment Study

Who this might be right for
Retinal DiseaseMacular DegenerationHereditary Retinal Dystrophy+2 more
MD Stem Cells 300
Large-scale testing (Phase 3)Active Not RecruitingNCT05730699
What this trial is testing

Efficacy and Safety of Divozilimab in Patients With Neuromyelitis Optica Spectrum Disorders (AQUARELLE)

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Biocad 105
Post-approval studies (Phase 4)Looking for participantsNCT07410039
What this trial is testing

Therapy in the Acute Phase of NMOSD: A Multicenter Prospective Real-World Study

Who this might be right for
Neuromyelitis Optica Spectrum Disorder Attack
Chinese PLA General Hospital 200
Not applicableUnknownNCT03370965
What this trial is testing

Optic Neuritis Differential Diagnosis Study

Who this might be right for
Optic NeuritisNeuromyelitis OpticaMultiple Sclerosis
University Hospital Center of Martinique 150
Large-scale testing (Phase 3)Study completedNCT02073279
What this trial is testing

Efficacy and Safety Study of Satralizumab (SA237) as Monotherapy to Treat Participants With Neuromyelitis Optica (NMO) and Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
Neuromyelitis Optica (NMO)NMO Spectrum Disorder (NMOSD)
Hoffmann-La Roche 95
Post-approval studies (Phase 4)Not Yet RecruitingNCT07699770
What this trial is testing

Crisugabalin in NMOSD Neuropathic Pain: A Randomized, Double-Blind, Placebo-Controlled Exploratory Trial

Who this might be right for
Neuromyelitis Optica Spectrum Disorders (NMOSD)Neuropathic Pain
Tang-Du Hospital 110
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07809724
What this trial is testing

Efficacy and Safety of Low-Dose IL-2 in Neuromyelitis Optica Spectrum Disorder

Who this might be right for
Neuromyelitis Optica Spectrum Disorder (NMOSD)
Peking University People's Hospital 60
Early research (Phase 1)Not Yet RecruitingNCT07676266
What this trial is testing

C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy

Who this might be right for
Multiple Sclerosis (MS)Myasthenia Gravis (MG)Neuromyelitis Optica Spectrum Disorder+3 more
The Affiliated Hospital of Qingdao University 18
Not applicableNot Yet RecruitingNCT06903130
What this trial is testing

Clinical Study to Evaluate the Effects of the Complement C5 Inhibitor Ravulizumab on Serum Neurofilament Light Chain (sNfL) and Glial Fibrillary Acidic Protein (sGFAP) Levels in Patients With Aquaporin-4-Positive (AQP4-Ab+) Neuromyelitis Optica Spectrum Disorder (NMOSD)

Who this might be right for
NMOSD
National and Kapodistrian University of Athens 40
Not applicableLooking for participantsNCT03900221
What this trial is testing

French Registry for Monitoring Pregnancies for Multiple Sclerosis

Who this might be right for
Sclerosis, MultipleNeuromyelitis Optica Spectrum DisorderMyelin Oligodendrocyte Glycoprotein (MOG)-Antibody Related Disorders+1 more
Hospices Civils de Lyon 1,500
Not applicableNot Yet RecruitingNCT07526298
What this trial is testing

Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
IRCCS San Raffaele 50
Post-approval studies (Phase 4)Ended earlyNCT05269667
What this trial is testing

A Study In Neuromyelitis Optica Spectrum Disorder (NMOSD) With Satralizumab As An Intervention

Who this might be right for
Neuromyelitis Optica Spectrum DisorderNMOSD
Hoffmann-La Roche 4
Not applicableUnknownNCT04822623
What this trial is testing

Imaging Evaluation of Central Nervous Autoimmune Diseases

Who this might be right for
MS (Multiple Sclerosis)NMO Spectrum Disorder
Qilu Hospital of Shandong University 300
Early research (Phase 1)Looking for participantsNCT06620809
What this trial is testing

The Safety and Efficacy of NouvSoma001 in Neuromyelitis Optica Spectrum Disorders

Who this might be right for
Neuromyelitis Optica Spectrum Disorders
Tongji Hospital 69
Next Page